Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. Summary
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
Real-time Euronext Paris  -  11:35:27 2023-05-31 am EDT
245.60 EUR   -1.25%
05/25Sartorius Stedim Biotech : Target cut by -8.5%
Alphavalue
05/22Sartorius and Sartorius Stedim under pressure after analyst report
DP
05/04Sartorius Stedim Biotech : announces CFO transition
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
05/25/2023 05/26/2023 05/29/2023 05/30/2023 05/31/2023 Date
243.3(c) 244.6(c) 246.3(c) 248.7(c) 245.6(c) Last
37 082 41 839 20 864 48 407 111 561 Volume
-0.49% +0.53% +0.70% +0.97% -1.25% Change
More quotes
Estimated financial data (e)
Sales 2023 3 433 M 3 658 M 3 658 M
Net income 2023 661 M 705 M 705 M
Net Debt 2023 3 005 M 3 202 M 3 202 M
P/E ratio 2023 34,2x
Yield 2023 0,56%
Sales 2024 3 880 M 4 136 M 4 136 M
Net income 2024 761 M 811 M 811 M
Net Debt 2024 2 621 M 2 794 M 2 794 M
P/E ratio 2024 28,7x
Yield 2024 0,62%
Capitalization 22 635 M 24 124 M 24 124 M
EV / Sales 2023 7,47x
EV / Sales 2024 6,51x
Nbr of Employees 11 934
Free-Float 26,2%
More Financials
Company
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and... 
More about the company
Ratings of Sartorius Stedim Biotech
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about SARTORIUS STEDIM BIOTECH
05/25Sartorius Stedim Biotech : Target cut by -8.5%
Alphavalue
05/22Sartorius and Sartorius Stedim under pressure after analyst report
DP
05/04Sartorius Stedim Biotech : announces CFO transition
PU
04/30SARTORIUS STEDIM BIOTECH : Monthly statement on voting rights
CO
04/24Sartorius Stedim Biotech : Weak start puts FY 23 guidance at ri..
Alphavalue
04/21US Futures Fall, European Stocks Mixed
DJ
04/20European Trading Ends Mixed Amid Upbeat Eurozone Data, Earnings Misses
MT
04/20Global markets live: L'Oréal, AT&T, Tesla, Blackstone, American Expr..
MS
04/20Sartorius Stedim Biotech : Conference Call Q1|2023 Presentation
PU
04/20Sartorius Aktiengesellschaft, Sartorius Stedim Biotech S.A., Q1 2023 Earnings Call, Apr..
CI
04/20Corona discontinuation and high costs weigh on Sartorius - share price plummets
DP
04/20Corona discontinuation and higher costs weigh on Sartorius - share price slumps
DP
04/20Sartorius Stedim Biotech Posts Lower Q1 Profit; Revenue Declines
MT
04/20Sartorius Stedim Biotech Sa : First-quarter results 2023 of Sartorius Stedim Biotech
EQ
04/20SARTORIUS STEDIM BIOTECH : 1st quarter results
CO
More news
News in other languages on SARTORIUS STEDIM BIOTECH
05/25Opiniones de los analistas del día: CaixaBank, Aixtro..
05/25Bolsa de Madrid: Nvidia hace saltar la banca
05/25Nvidia fait sauter la banque
05/25Avis d'analystes du jour : Sartorius Stedim Biotech, Soitec, bi..
05/25Sartorius Stedim Biotech : Réduction de l'objectif de -8,5%
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Stock Trading Strategies
SARTORIUS STEDIM BIOTECH - 01/04
A support level that should be taken advantage of
BUY
More Stock Trading Analysis
ETFs positioned on SARTORIUS STEDIM BIOTECHETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Deka STOXX Europe Strong Growth 20 - EUR4.08%0.09%Europe
Deka STOXX Europe Strong Style Composite 40 - EUR1.86%-2.36%Europe
VanEck Global Healthcare Leaders ETF - AUD1.75%-1.61%-NC
Fidelity International High Quality Index E...1.02%-0.74%NC
UBS ETF ? Factor MSCI EMU Quality (EUR) A-...0.95%-1.08%Europe
More ETFs positioned on SARTORIUS STEDIM BIOTECH
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 245,60 €
Average target price 363,82 €
Spread / Average Target 48,1%
EPS Revisions
Managers and Directors
RenÚ Fßber Chief Executive Officer & Director
Joachim Kreuzburg Chairman
Oscar-Werner Reif Executive VP-Research & Development
Anne-Marie Graffin Independent Non-Executive Director
Susan Dexter Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS STEDIM BIOTECH-17.79%24 572
ABBOTT LABORATORIES-7.36%176 868
MEDTRONIC PLC6.15%109 792
BECTON, DICKINSON AND COMPANY-6.26%67 706
DEXCOM, INC.0.28%44 020
HOYA CORPORATION36.44%43 854
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer